Insulin Resistance, β-Cell Dysfunction, and Conversion to Type 2 Diabetes in a Multiethnic Population
暂无分享,去创建一个
[1] K. Narayan,et al. Clinical risk factors, DNA variants, and the development of type 2 diabetes. , 2009, The New England journal of medicine.
[2] R. Bergman,et al. The insulin resistance atherosclerosis study (IRAS) objectives, design, and recruitment results. , 1995, Annals of epidemiology.
[3] E. Lambert,et al. Insulin Response in Relation to Insulin Sensitivity: An Appropriate β-Cell Response in Black South African Women , 2009, Diabetes Care.
[4] E. Lambert,et al. Insulin Response in Relation to Insulin Sensitivity , 2009, Diabetes Care.
[5] S. Fowler,et al. Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin. , 2005, Diabetes.
[6] D. Schuster,et al. Impaired insulin sensitivity, insulin secretion, and glucose effectiveness predict future development of impaired glucose tolerance and type 2 diabetes in pre-diabetic African Americans: implications for primary diabetes prevention. , 2004, Diabetes care.
[7] Nicholette D. Palmer,et al. A genome-wide association scan for acute insulin response to glucose in Hispanic-Americans: the Insulin Resistance Atherosclerosis Family Study (IRAS FS) , 2009, Diabetologia.
[8] E. Ravussin,et al. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. , 1993, The New England journal of medicine.
[9] R. Bergman,et al. Increased Insulin Resistance and Insulin Secretion in Nondiabetic African-Americans and Hispanics Compared With Non-Hispanic Whites: The Insulin Resistance Atherosclerosis Study , 1996, Diabetes.
[10] R. N. Bergman,et al. Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study , 1992, The Lancet.
[11] Nicholette D. Palmer,et al. Quantitative Trait Analysis of Type 2 Diabetes Susceptibility Loci Identified From Whole Genome Association Studies in the Insulin Resistance Atherosclerosis Family Study , 2008, Diabetes.
[12] C. Bogardus,et al. Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type 2 diabetes development. , 2001, Diabetes care.
[13] R. Bergman,et al. Insulin Sensitivity and Acute Insulin Response in African-Americans, Non-Hispanic Whites, and Hispanics With NIDDM: The Insulin Resistance Atherosclerosis Study , 1997, Diabetes.
[14] L. Bouter,et al. Absence of an acute insulin response predicts onset of type 2 diabetes in a Caucasian population with impaired glucose tolerance. , 2008, The Journal of clinical endocrinology and metabolism.
[15] S. Haffner,et al. The natural course of beta-cell function in nondiabetic and diabetic individuals: the Insulin Resistance Atherosclerosis Study. , 2006, Diabetes.
[16] R. J. Hayes,et al. United Kingdom Prospective Diabetes Study 24: A 6-Year, Randomized, Controlled Trial Comparing Sulfonylurea, Insulin, and Metformin Therapy in Patients with Newly Diagnosed Type 2 Diabetes That Could Not Be Controlled with Diet Therapy , 1998, Annals of Internal Medicine.
[17] S. Fowler,et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. , 2002 .
[18] P. Bennett,et al. SEQUENTIAL CHANGES IN SERUM INSULIN CONCENTRATION DURING DEVELOPMENT OF NON-INSULIN-DEPENDENT DIABETES , 1989, The Lancet.
[19] S. Kahn,et al. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes , 2003, Diabetologia.
[20] R N Bergman,et al. MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test. , 1986, Computer methods and programs in biomedicine.
[21] P. Bennett,et al. A two-step model for development of non-insulin-dependent diabetes. , 1991, The American journal of medicine.
[22] R. Parker,et al. Insulin resistance is a poor predictor of type 2 diabetes in individuals with no family history of disease , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[23] H. Lebovitz,et al. Patterns of Glucose and Lipid Abnormalities in Black NIDDM Subjects , 1991, Diabetes Care.
[24] P. Home,et al. Clinical guidelines and evidence review for Type 2 diabetes: management of blood glucose , 2002 .
[25] Peter Almgren,et al. Predictors of and longitudinal changes in insulin sensitivity and secretion preceding onset of type 2 diabetes. , 2005, Diabetes.